R1 RCM to buy VisitPay for $300M

by on

VisitPay’s patient billing tools will bolster R1 RCM’s patient experience platform, CEO Joe Flanagan said on a quarterly earnings call with investment analysts. R1 posted $342.6 million in revenue for 2021’s first quarter, up 6.9%.

VisitPay’s patient billing tools will bolster R1 RCM’s patient experience platform, CEO Joe Flanagan said on a quarterly earnings call with investment analysts. R1 posted $342.6 million in revenue for 2021’s first quarter, up 6.9%.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: